aluates Reports

$ 0.0

Automative

Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-13K18428

BUY CHAPTERS

Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Research Report 2024

Code: QYRE-Auto-13K18428

Report

September 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

AOC

Avidity Biosciences

Denali Therapeutics

Dyne Therapeutics

Tallac Therapeutics

Gennao Bio

ChainGen Bio

Ractigen Therapeutics

Antibody Oligonucleotide Conjugates(AOC) Drug Market

Antibody Oligonucleotide Conjugates(AOC) Drug are a new class of synthetic bioconjugates consisting of monoclonal antibodies and oligonucleotides (ONs), which have attracted considerable attention in the application of modern biotechnology. In recent years, biopharmaceutical companies have focused a lot of attention and resources on the development of advanced drugs based on AOC technology. Companies such as Avidity, Dyne, Tallac, Denali, and Gennao Bio are developing treatments for various muscle diseases, such as myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy, as well as cancer and central nervous system diseases.

The global Antibody Oligonucleotide Conjugates(AOC) Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Antibody Oligonucleotide Conjugates(AOC) Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Antibody Oligonucleotide Conjugates(AOC) Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Antibody Oligonucleotide Conjugates(AOC) Drug in DMI is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Antibody Oligonucleotide Conjugates(AOC) Drug include Avidity Biosciences, Dyne Therapeutics, Tallac Therapeutics, Denali Therapeutics, Gennao Bio, ChainGen Bio, Ractigen Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Antibody Oligonucleotide Conjugates(AOC) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Oligonucleotide Conjugates(AOC) Drug.

The Antibody Oligonucleotide Conjugates(AOC) Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Oligonucleotide Conjugates(AOC) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody Oligonucleotide Conjugates(AOC) Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibody Oligonucleotide Conjugates(AOC) Drug Market Report

Report Metric	Details
Report Name	Antibody Oligonucleotide Conjugates(AOC) Drug Market
Segment by Type	Antisense Oligonucleotide(ASO) Based Small Interfering RNA(siRNA) Based Aptamer Based
Segment by Application	DMI DMD FSHD Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Avidity Biosciences, Dyne Therapeutics, Tallac Therapeutics, Denali Therapeutics, Gennao Bio, ChainGen Bio, Ractigen Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Oligonucleotide Conjugates(AOC) Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody Oligonucleotide Conjugates(AOC) Drug Market report?

Ans: The main players in the Antibody Oligonucleotide Conjugates(AOC) Drug Market are Avidity Biosciences, Dyne Therapeutics, Tallac Therapeutics, Denali Therapeutics, Gennao Bio, ChainGen Bio, Ractigen Therapeutics

What are the Application segmentation covered in the Antibody Oligonucleotide Conjugates(AOC) Drug Market report?

Ans: The Applications covered in the Antibody Oligonucleotide Conjugates(AOC) Drug Market report are DMI, DMD, FSHD, Cancer

What are the Type segmentation covered in the Antibody Oligonucleotide Conjugates(AOC) Drug Market report?

Ans: The Types covered in the Antibody Oligonucleotide Conjugates(AOC) Drug Market report are Antisense Oligonucleotide(ASO) Based, Small Interfering RNA(siRNA) Based, Aptamer Based

Recommended Reports

Oligonucleotide Drugs

Antibody Drug Conjugates

RNA and Antisense Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antisense Oligonucleotide(ASO) Based

1.2.3 Small Interfering RNA(siRNA) Based

1.2.4 Aptamer Based

1.3 Market by Application

1.3.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 DMI

1.3.3 DMD

1.3.4 FSHD

1.3.5 Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Perspective (2019-2030)

2.2 Global Antibody Oligonucleotide Conjugates(AOC) Drug Growth Trends by Region

2.2.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antibody Oligonucleotide Conjugates(AOC) Drug Historic Market Size by Region (2019-2024)

2.2.3 Antibody Oligonucleotide Conjugates(AOC) Drug Forecasted Market Size by Region (2025-2030)

2.3 Antibody Oligonucleotide Conjugates(AOC) Drug Market Dynamics

2.3.1 Antibody Oligonucleotide Conjugates(AOC) Drug Industry Trends

2.3.2 Antibody Oligonucleotide Conjugates(AOC) Drug Market Drivers

2.3.3 Antibody Oligonucleotide Conjugates(AOC) Drug Market Challenges

2.3.4 Antibody Oligonucleotide Conjugates(AOC) Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Oligonucleotide Conjugates(AOC) Drug Players by Revenue

3.1.1 Global Top Antibody Oligonucleotide Conjugates(AOC) Drug Players by Revenue (2019-2024)

3.1.2 Global Antibody Oligonucleotide Conjugates(AOC) Drug Revenue Market Share by Players (2019-2024)

3.2 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antibody Oligonucleotide Conjugates(AOC) Drug Revenue

3.4 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Concentration Ratio

3.4.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Oligonucleotide Conjugates(AOC) Drug Revenue in 2023

3.5 Global Key Players of Antibody Oligonucleotide Conjugates(AOC) Drug Head office and Area Served

3.6 Global Key Players of Antibody Oligonucleotide Conjugates(AOC) Drug, Product and Application

3.7 Global Key Players of Antibody Oligonucleotide Conjugates(AOC) Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Oligonucleotide Conjugates(AOC) Drug Breakdown Data by Type

4.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Historic Market Size by Type (2019-2024)

4.2 Global Antibody Oligonucleotide Conjugates(AOC) Drug Forecasted Market Size by Type (2025-2030)

5 Antibody Oligonucleotide Conjugates(AOC) Drug Breakdown Data by Application

5.1 Global Antibody Oligonucleotide Conjugates(AOC) Drug Historic Market Size by Application (2019-2024)

5.2 Global Antibody Oligonucleotide Conjugates(AOC) Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size (2019-2030)

6.2 North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024)

6.4 North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size (2019-2030)

7.2 Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024)

7.4 Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size (2019-2030)

8.2 Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size (2019-2030)

9.2 Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024)

9.4 Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size (2019-2030)

10.2 Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Avidity Biosciences

11.1.1 Avidity Biosciences Company Details

11.1.2 Avidity Biosciences Business Overview

11.1.3 Avidity Biosciences Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.1.4 Avidity Biosciences Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.1.5 Avidity Biosciences Recent Development

11.2 Dyne Therapeutics

11.2.1 Dyne Therapeutics Company Details

11.2.2 Dyne Therapeutics Business Overview

11.2.3 Dyne Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.2.4 Dyne Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.2.5 Dyne Therapeutics Recent Development

11.3 Tallac Therapeutics

11.3.1 Tallac Therapeutics Company Details

11.3.2 Tallac Therapeutics Business Overview

11.3.3 Tallac Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.3.4 Tallac Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.3.5 Tallac Therapeutics Recent Development

11.4 Denali Therapeutics

11.4.1 Denali Therapeutics Company Details

11.4.2 Denali Therapeutics Business Overview

11.4.3 Denali Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.4.4 Denali Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.4.5 Denali Therapeutics Recent Development

11.5 Gennao Bio

11.5.1 Gennao Bio Company Details

11.5.2 Gennao Bio Business Overview

11.5.3 Gennao Bio Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.5.4 Gennao Bio Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.5.5 Gennao Bio Recent Development

11.6 ChainGen Bio

11.6.1 ChainGen Bio Company Details

11.6.2 ChainGen Bio Business Overview

11.6.3 ChainGen Bio Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.6.4 ChainGen Bio Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.6.5 ChainGen Bio Recent Development

11.7 Ractigen Therapeutics

11.7.1 Ractigen Therapeutics Company Details

11.7.2 Ractigen Therapeutics Business Overview

11.7.3 Ractigen Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Introduction

11.7.4 Ractigen Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

11.7.5 Ractigen Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

AOC

Avidity Biosciences

Denali Therapeutics

Dyne Therapeutics

Tallac Therapeutics

Gennao Bio

ChainGen Bio

Ractigen Therapeutics

List of Tables

Table 1. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antisense Oligonucleotide(ASO) Based

Table 3. Key Players of Small Interfering RNA(siRNA) Based

Table 4. Key Players of Aptamer Based

Table 5. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Region (2019-2024)

Table 9. Global Antibody Oligonucleotide Conjugates(AOC) Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Region (2025-2030)

Table 11. Antibody Oligonucleotide Conjugates(AOC) Drug Market Trends

Table 12. Antibody Oligonucleotide Conjugates(AOC) Drug Market Drivers

Table 13. Antibody Oligonucleotide Conjugates(AOC) Drug Market Challenges

Table 14. Antibody Oligonucleotide Conjugates(AOC) Drug Market Restraints

Table 15. Global Antibody Oligonucleotide Conjugates(AOC) Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Players (2019-2024)

Table 17. Global Top Antibody Oligonucleotide Conjugates(AOC) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug as of 2023)

Table 18. Ranking of Global Top Antibody Oligonucleotide Conjugates(AOC) Drug Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Antibody Oligonucleotide Conjugates(AOC) Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Antibody Oligonucleotide Conjugates(AOC) Drug, Headquarters and Area Served

Table 21. Global Key Players of Antibody Oligonucleotide Conjugates(AOC) Drug, Product and Application

Table 22. Global Key Players of Antibody Oligonucleotide Conjugates(AOC) Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Antibody Oligonucleotide Conjugates(AOC) Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Antibody Oligonucleotide Conjugates(AOC) Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Antibody Oligonucleotide Conjugates(AOC) Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Antibody Oligonucleotide Conjugates(AOC) Drug Revenue Market Share by Application (2019-2024)

Table 30. Global Antibody Oligonucleotide Conjugates(AOC) Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Antibody Oligonucleotide Conjugates(AOC) Drug Revenue Market Share by Application (2025-2030)

Table 32. North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. Avidity Biosciences Company Details

Table 48. Avidity Biosciences Business Overview

Table 49. Avidity Biosciences Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 50. Avidity Biosciences Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 51. Avidity Biosciences Recent Development

Table 52. Dyne Therapeutics Company Details

Table 53. Dyne Therapeutics Business Overview

Table 54. Dyne Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 55. Dyne Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 56. Dyne Therapeutics Recent Development

Table 57. Tallac Therapeutics Company Details

Table 58. Tallac Therapeutics Business Overview

Table 59. Tallac Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 60. Tallac Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 61. Tallac Therapeutics Recent Development

Table 62. Denali Therapeutics Company Details

Table 63. Denali Therapeutics Business Overview

Table 64. Denali Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 65. Denali Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 66. Denali Therapeutics Recent Development

Table 67. Gennao Bio Company Details

Table 68. Gennao Bio Business Overview

Table 69. Gennao Bio Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 70. Gennao Bio Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 71. Gennao Bio Recent Development

Table 72. ChainGen Bio Company Details

Table 73. ChainGen Bio Business Overview

Table 74. ChainGen Bio Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 75. ChainGen Bio Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 76. ChainGen Bio Recent Development

Table 77. Ractigen Therapeutics Company Details

Table 78. Ractigen Therapeutics Business Overview

Table 79. Ractigen Therapeutics Antibody Oligonucleotide Conjugates(AOC) Drug Product

Table 80. Ractigen Therapeutics Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024) & (US$ Million)

Table 81. Ractigen Therapeutics Recent Development

Table 82. Research Programs/Design for This Report

Table 83. Key Data Information from Secondary Sources

Table 84. Key Data Information from Primary Sources

Table 85. Authors List of This Report

List of Figures

Figure 1. Antibody Oligonucleotide Conjugates(AOC) Drug Picture

Figure 2. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Type: 2023 VS 2030

Figure 4. Antisense Oligonucleotide(ASO) Based Features

Figure 5. Small Interfering RNA(siRNA) Based Features

Figure 6. Aptamer Based Features

Figure 7. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Application: 2023 VS 2030

Figure 9. DMI Case Studies

Figure 10. DMD Case Studies

Figure 11. FSHD Case Studies

Figure 12. Cancer Case Studies

Figure 13. Antibody Oligonucleotide Conjugates(AOC) Drug Report Years Considered

Figure 14. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Region: 2023 VS 2030

Figure 17. Global Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Players in 2023

Figure 18. Global Top Antibody Oligonucleotide Conjugates(AOC) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Oligonucleotide Conjugates(AOC) Drug as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Antibody Oligonucleotide Conjugates(AOC) Drug Revenue in 2023

Figure 20. North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Country (2019-2030)

Figure 22. United States Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Country (2019-2030)

Figure 26. Germany Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Region (2019-2030)

Figure 34. China Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Country (2019-2030)

Figure 42. Mexico Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Antibody Oligonucleotide Conjugates(AOC) Drug Market Share by Country (2019-2030)

Figure 46. Turkey Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Antibody Oligonucleotide Conjugates(AOC) Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Avidity Biosciences Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 50. Dyne Therapeutics Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 51. Tallac Therapeutics Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 52. Denali Therapeutics Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 53. Gennao Bio Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 54. ChainGen Bio Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 55. Ractigen Therapeutics Revenue Growth Rate in Antibody Oligonucleotide Conjugates(AOC) Drug Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antibody Oligonucleotide Conjugates AOC Drug CDMO Market Research Report 2024

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global Oligonucleotide Bioconjugation Service Market Research Report 2024

Global Oligonucleotide Therapeutics Market Research Report 2024

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Peptide and Oligonucleotide Drugs Market Research Report 2024

Global GalNAc Oligonucleotide Conjugates Market Research Report 2024

Global Antibody drug Conjugates Market Insights Forecast to 2030

Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024

Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global ASO based Drug Market Research Report 2024

Global Oligonucleotide Conjugates Market Research Report 2024

Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024

Antibody drug Conjugate for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugate ADC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024

Global Antisense ODN Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions